Human cytomegalovirus is a common human pathogen that can cause life-threatening disease under certain conditions. During infection of host cells, the virus expresses regulatory proteins such as IE72 and IE86 that are important for viral propagation. IE86 plays a critical role in the modulation of viral replication as well as host cell cycle control and apoptosis. In this study, a Tet-On system was used to quantify the effect of IE86 on apoptosis and p53 expression. Our results indicate that IE86 inhibits tumor necrosis factor (TNF)-induced apoptosis and that the anti-apoptotic activity of this viral protein correlates with its expression levels. In addition, IE86 did not alter the mRNA level of p53. The system developed should provide a method for functional analysis of human cytomegalovirus (HCMV) IE86 protein.
Human cytomegalovirus (HCMV), a ubiquitous betaherpes virus, infects the majority of the population. It can establish a persistent infection that can cause lifethreatening disease in immunocompromised individuals such as transplant recipients and AIDS patients. HCMV is also the major cause of virus-related birth defects in humans, with an incidence of about 0.2-2% of live births. 1) Among HCMV-infected neonates, at least 10-17% exhibit neurological symptoms. 2) Pathological and etiological studies also suggest that HCMV infection is associated with atherosclerosis. 3, 4) Following infection of permissive cells, transcription of the HCMV genome is activated and progresses through three phases, designated immediate early (IE), early, and late. The IE genes are expressed independently of any de novo protein synthesis and encode important functional proteins. 5) Among the IE proteins, the most abundantly expressed are IE72 and IE86. These are derived from one single transcription unit by differential splicing; they share the same N-terminal 85 amino acids. 6) Therefore, it is possible that IE72 and IE86 function similarly during the course of viral infection. The importance of IE86 for HCMV infection has been demonstrated by transfection of a bacterial artificial chromosome (BAC) clone containing a complete HCMV genome. This resulted in virus production in permissive cells, whereas transfection of the BAC containing the full length of the HCMV genome lacking the IE86 coding sequence failed to generate plaques and was unable to induce the expression of several viral early genes. 7) The failure of IE86-deficient strains of HCMV to replicate properly is consistent with its role as a potent transcriptional activator of numerous viral early genes, as well as host cell genes. Several studies have reported that IE86 can affect the expression of factors associated with cell cycle regulation and promotes the transition from the G 1 -to the S-phase but then arrests at the early S-phase. 5, [8] [9] [10] In addition to regulation of cell cycle progression, other research has shown that IE86 modulates the function of some factors, such as p53 and NF-B, that are involved in cell proliferation and apoptosis control. [11] [12] [13] These data indicate that IE86 acts to establish a suitable environment for HCMV infection by regulating cell cycle progression and apoptosis in infected cells.
In the present study, a well characterized Tet system was used to study the effect of IE86 on cell apoptosis and p53 expression. This system has been widely used to regulate exogenous gene expression in a variety of cells in culture as well as in a number of organs in vivo. 14, 15) The Tet system is composed of two primary elements, the regulatory protein and the response plasmid, which express a gene of interest under the control of the tetracycline-response element (TRE). In the original version of the system (Tet-Off), gene expression is stimulated by tetracycline controlled transactivator (tTA). In the presence of doxycycline, tTA is unable to bind the TRE, whereas removal of this antibiotic allows activation of transgene expression. The advanced version of the Tet system (Tet-On) uses a reverse transactivator (rtTA) that remains silent without doxycycline.
16) The addition of doxycycline switches on the rtTA and then activates the expression of a Tet-dependent gene.
The Tet-On system was used to study the effect of IE86 on apoptosis. We found that this system allowed for controlled expression of IE86 in an inducible manner and that the product expressed by this system inhibited cell apoptosis. We also used the system to quantify the expression of p53. It provides a method for functional analysis of HCMV IE86.
Materials and Methods
Plasmid construction. All plasmids were propagated in Escherichia coli strain DH5. Plasmid pIEP86AD169, which contains a full-length encoding sequence of IE86 of the HCMV AD169 strain, was a kind gift from Professor James C. Alwine (University of Pennsylvania). To generate plasmid pEGFP/IE86, a full-length IE86 cDNA except for a deletion of the ending codon was amplified from pIEP86AD169 by the PCR method using primers: fwd 5 0 -cccaagcttgggatggagtcctctgccaagag-3 0 and rev 5 0 -cgcggatccgcgctgagacttgttcctcag-3 0 . The DNA fragment was digested with Hind III and BamH I, gel purified, and inserted into pEGFP-N3 upstream of the EGFP coding sequence. For inducible expression of IE86, primers 5 0 -cgcggatccgcgatggagtcctctgccaagag-3 0 and 5 0 -gcggccgcttactgagacttgttcctcagg-3 0 were used to amplify a 1,760-bp product from pIEP86AD169. After digestion of the PCR product with BamH I and Not I, the DNA fragment was purified and ligated to pTRE2hyg (BD Biosciences Clontech, Palo Alto, CA) to generate plasmid pTRE/IE86.
Cell culture and transfection. MRC-5 cells, a human embryo lung fibroblast cell line, were grown in Minimum Essential Media (GIBCO, Grand Island, NY) supplemented with 10% fetal bovine serum, sodium pyruvate (1 mmol/l), penicillin (100 m/ml) and streptomycin (100 mg/ml). The Tet-On Hela cell line (BD Biosciences Clontech, Palo Alto, CA), which can express the regulatory protein of Tet-On system, was cultured in DMEM (GIBCO, Grand Island, NY) supplied with 10% Tet-On serum (BD Biosciences Clontech, Palo Alto, CA), 2 mM L-glutamine, 100 mg/ml G418, penicillin, and streptomycin. The cultures were maintained in 50 ml, 25 cm 2 culture flasks and were passaged routinely on reaching confluence.
For transfection, cells were plated in 6-well plates. On reaching 90-95% confluence, Tet-On Hela cells and MRC-5 cells were transfected with pTRE/IE86 and pEGFP/IE86 respectively using Hifectin II eukaryocyte transfection reagent (Applygen, Beijing, China) and cultured with 2 ml medium, as described above. Forty-eight h later, hygromycin B (200 mg/ml) was added into the culture medium of Hela cells to select stably transfected cell lines. When most cells appeared to be dying, the dose of hygromycin B was decreased to 100 mg/ml and maintained at that level for 2 weeks. Hygromycin-resistant clones were then picked and transferred into 25 cm 2 culture flasks and cultured with the same culture medium to allow cell proliferation.
Western blot analysis. The cells were pretreated for 30 h with doxycycline (Dox) containing culture medium at doses of 0 mg/ml, 0.1 mg/ml, 1.0 mg/ml, or 5.0 mg/ml. Then 5 Â 10 6 cells of each sample were collected and rinsed 3 times in cold phosphate-buffer saline (PBS). Pelleted cells were resuspended in equal volumes of cell lysis buffer (Genmed Scientifics, Arlington, MA) and incubated on ice for 30 min. During the course of incubation, the suspension was vortexed for 15 s every 10 min. The insoluble fraction was pelleted by centrifugation at 12;000 Â g for 10 min at 4 C. Twenty mg of protein was boiled in 1 Â Laemmli sample buffer containing 1.25% 2-mercaptoethanol and 100 mmol/l dithiothreitol and subjected to SDS-polyacrylamide gel electrophoresis. The proteins were transferred onto a polyvinylidene difluoride membrane, which was subsequently blocked overnight. The membrane was reacted with primary antibodies including mouse anti-IE86 (ViroStat, Portland, Maine) or -actin (Santa Cruz Biotechnology, Santa Cruz, CA), and then was incubated with horseradish peroxidase-conjugated goat anti-mouse IgG (Boster, Wuhan, China). Finally, the reactive proteins were detected with a DAB kit (Boster, Wuhan, China).
Immunocytochemistry. Forty-eight h after transfection, the cells were fixed with 4% paraformaldehyde for 20 min, permeabilized in 0.2% Triton X-100 at room temperature, and then reacted with mouse monoclonal antibody to HCMV IE86. Antibody was detected using anti-mouse TRITC conjugate and visualized using a fluorescence microscope.
RT-PCR assay. Total RNA was isolated from cells expressing and not expressing IE86 using Trizol according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). First-strand cDNA synthesis was conducted using a random hexamer primer and AMV reverse transcriptase (Promega, Madison, WI). The derived cDNA products were PCR amplified using primer pairs as follows: IE86 DNA fragmentation assay. Two different treatments were employed to induce apoptosis. First, TNF-(100 ng/ml) in combination with 25 ng of actinomycin D (ACTD) per ml was administered to cultures of Hela cells after induction for 30 h with Dox. Second, TNF-(200 ng/ml) and ACTD (50 ng/ml) were added to the cultures of MRC-5 cells after 48 h of transfection. The apoptotic effects of these two cell lines were then studied 8 h later.
Apoptosis was monitored by DNA fragmentation assay 17) and light microscopy. The cells were grown in 25 cm 2 cell culture flasks. Cells (1 Â 10 6 ) were collected by trypsinization, washed with PBS, and centrifuged. The pellet was incubated with a cell lysis buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 10 mM EDTA, 100 ug/ml proteinase K, and 1% SDS) at 37 C overnight. After extraction with phenol saturate, phenol/chloroform, and chloroform, the DNA was precipitated with 100% ethanol and dissolved in a Tris-EDTA buffer (pH 8.0) with RNase A at 37 C for 1 h. Absorbance was then read at 260 and 280 nm, and the DNA was separated in 2.0% agarose gel containing 0.5 mg/ml ethidium bromide. The bands were visualized using a UV transilluminator.
Flow cytometry. An annexin V-FITC apoptosis detection kit (Beyotime, Haimen, China) was used to measure the level of cell apoptosis according to the manufacturer's instructions. The cells were trypsinized in DMEM, collected by centrifugation, and resuspended in 200 ml of binding buffer that contained annexin V. After incubation at room temperature for 10 min in the dark, the cells were centrifuged and resuspended in 200 ml of PI containing binding buffer. Finally, they were analyzed by flow cytometry (BD Biosciences, San Jose, CA). Several controls were used to optimize the instrument settings and determine the gating for the Window-based platform.
Results

Expression of IE86 induced by Doxycycline
In this experiment, a Tet-On system was used to express IE86. Following transfection of Tet-On Hela cells with plasmid pTRE/IE86, the IE86 stably-expressing cell line (line tetIE86Hel) was generated and characterized. To confirm changes in IE86 expression, total proteins were extracted from cells treated with and without Doxycycline in culture medium. Western blotting analysis revealed that expression of IE86 occurred in line tetIE86Hel with and without Doxycycline induction (Fig. 1A) . The reason for this apparently unregulated expression is not clear. It is possible that the regulatory protein rtTA retained some affinity for tetO sequences even in the absence of Doxycycline, and resulted in IE86 expression. Pervious reports have described transgenic activation in cells not receiving Doxycycline. 18) Despite this background expression, a striking increase in the level of expression of IE86 was observed when higher doses of Doxycycline were added to the culture. Interestingly, however, the level of IE86 decreased after the tetIE86Hel cell line was induced with a high dose of Doxycycline. Relative density analysis showed that the expression of IE86 was a little lower at 5.0 mg/ml of Dox than it was at 0.1 mg/ml (Fig. 1B) . The reason for this effect is unknown, but it may be that IE86 autorepressed the major immediate early promoter (MIEP) used in the Tet-On system. In addition, several studies have demonstrated that IE86 can negatively autoregulate its own promoter either through direct binding to the so-called cis repression sequence or by interacting with histone deacetylase and histone methyltransferases. These latter interactions result in repression of viral MIEP. [19] [20] [21] Our results indicate that IE86 was expressed in a dose-dependent manner in the presence of low doses of Doxycycline (5 1:0 mg/ml).
HCMV IE86 blocked apoptosis induced by TNF-in Hela cells
Tet-On Hela cells, which underwent apoptosis when exposed to TNF-in our pilot experiments, were transfected with a plasmid, pTRE/IE86. The stable cell line, tetIE86Hel, was induced with and without Doxycycline, and 30 h later the cells were treated with TNF-(100 ng/ml) in the presence of Actinomycin D (25 ng/ml), which enhances the cellular response to TNFtreatment. The cultures were observed for evidence of TNF--induced apoptosis using an inverted microscope. The cells that were not pretreated with Doxycycline started to die about 4 h after treatment with TNF-and approximately 41% of them were dead after 8 h (Fig. 2A) . These cells exhibited the nuclear shrinkage and chromatin condensation characteristic of apoptosis. Cells expressing IE86 survived exposure to TNF-for either 4 h or 8 h and did not exhibit any characteristics of apoptosis ( Fig. 2A) . To confirm further that the cells underwent apoptosis, a DNA fragmentation assay was performed after 8 h of treatment with TNF-. DNA breakage (ladder) was observed in cells not treated with Doxycycline, whereas Doxycycline-induced cells did not exhibit any sign of DNA fragmentation (Fig. 2B) . These results suggest that IE86 can protect cells from apoptosis.
IE86 also blocks apoptosis of MRC-5 cells treated by TNF-
To assess further the hypothesis that IE86 inhibits apoptosis of HCMV permissive cells, we tested MRC-5 cells, which are fully permissive for HCMV replication. MRC-5 cells were transfected with either plasmid pEGFP/IE86 or plasmid pEGFP as a control. Fortyeight h later, immunochemistry was employed to assess the expression of IE86. Figure 3A shows, IE86 expressed in the nucleus of transfected cells, whereas no signal was seen in the control cells. We next treated the cells with TNF-(200 ng/ml) and Actinomycin D (50 ng/ml) for 8 h to evaluate cell apoptosis. A trypan blue exclusion assay indicated that 48.9% of the control cells were dead, while only 8.7% of the IE86-transfected cells were dead after exposure to TNF- (Fig. 3B) . In addition, a DNA fragmentation assay showed that the control cells but not IE86-transfected cells exhibited typical DNA breakage after treatment with TNF- (Fig. 3C) . These results indicate that IE86 also can inhibit apoptosis in HCMV-permissive cells. 
The ability of IE86 to inhibit apoptosis correlated with its expression level
To determine the relationship of anti-apoptotic efficiency and the expression level of IE86, tetIE86Hel cells were pretreated with different doses of Doxycycline before TNF-treatment. A flow cytometry analysis for apoptosis was performed 8 h after the cells were treated with TNF-. The percentage of apoptotic cells not induced by Doxycycline was 39.8%, the early and late apoptotic percentages being 23.8% and 16% respectively (Fig. 4A) . IE86-expressing cells that had been induced with Doxycycline at 0.1 or 1.0 mg/ml did not undergo apoptosis, and their apoptotic rates were less than 1% (Fig. 4B, C) . Unfortunately, 18.7% of the cells induced with a high level of Doxycycline (5.0 mg/ ml) exhibited obvious early apoptosis (Fig. 4D) . A recent study reported that higher dosage or longer treatment of Doxycycline can induce typical apoptosis in Hela cells. 22) Therefore, a cell viability assay was used to determine whether this apoptosis was caused by the treatment with Doxycycline. After treatment with different doses of Doxycycline for 30 h, no significant differences in cell viability were observed among the four groups (data not shown). These results indicate that Doxycycline did not affect cell viability when it was used at doses less than 5.0 mg/ml. Because the level of IE86 was somewhat lower at 5.0 mg/ml than that at 0.1 mg/ml, we suspect that the tetIE86Hel cells exhibited early apoptosis after exposure to high doses of Doxycycline because of the lower expression of IE86.
IE86 did not alter the expression of p53
The HCMV IE86 protein has documented ability to modulate the transcription of viral and cellular genes. Hence we asked if it might alter the expression of genes that have been shown to be involved in apoptosis, especially members of the p53 and bcl-2 gene families. p53 is a major effector of the cellular damage response, and it transcriptionally regulates gene products such as the cyclin-dependent kinase inhibitor p21, which in turn regulates cell cycle progression. 23) Activation of this transcription factor can lead either to cell cycle arrest or to apoptosis. We measured the expression level of p53 in tetIE86Hel cells in the presence and the absence of Doxycycline. RT-PCR assay indicated that the level of p53 was not affected by the expression of IE86 (Fig. 5A) , and there were no significant differences among the four groups tested. Similarly, in the MRC-5 cell line the expression of IE86 did not alter the level of p53 (Fig. 5B) , which further confirmed the effect of IE86 on p53 expression. 
Discussion
Programmed cell death or apoptosis is a mechanism by which unwanted cells are eliminated from an organism. Apoptosis also functions as a powerful innate defense against viral infection, inhibiting viral spread and persistence. 24) Thus, to replicate efficiently, viruses have evolved strategies to inhibit apoptosis. 25, 26) Some small DNA viruses have been reported to carry out this function by encoding distinct viral proteins such as adenovirus E1B, SV40 large T antigen, and HPV-16 E6. 24) HCMV, like other viruses, encodes some functional proteins that affect the cellular death receptor signaling pathway in infected cells. 27) In this study, two different cell lines, Tet-On Hela and MRC-5, were used to test the ability of HCMV IE86 to block apoptosis. DNA fragmentation assays indicated that IE86 blocked the induction of apoptosis by TNFwhen tested in Tet-On Hela cells constitutively expressing the HCMV protein and in MRC-5 cells transiently expressing it. Since the MRC-5 cells and Hela cells used in our study were permissive and nonpermissive for HCMV infection respectively, these data indicate that the ability of IE86 to protect cells from apoptosis does not differ for either HCMV permissive or nonpermissive cells. IE86 is one of the first HCMV gene products to be expressed after infection, allowing it antagonize apoptosis before the antiviral defense is instituted by the host cells. Such protection is probably extremely important to HCMV, given that its replication within an infected cell appears to progress very slowly in comparison to many other viruses. 6) To date, little information is available as to whether the anti-apoptotic activity of IE86 correlates with its expression level. This is due in part to the limitations of exogenous gene expression systems used in mammalian cells. The development of the Tet system provided us with the capacity to investigate this problem quantitatively. To quantify the relationship between IE86 expression and cell apoptosis, a Doxycycline-induced expression system (the Tet-On system) of IE86 was introduced into Hela cells. The expression level of IE86 during induction was measured by western blot assay. Our results demonstrated that IE86 was expressed in a dose-dependent manner in response to treatment with the inducer (Doxycycline) at lower doses (5 1:0 mg/ml), whereas significantly decreased IE86 was observed using a high (5.0 mg/ml) dose of Doxycycline. As a function of the expression pattern of IE86 in Doxycycline-induced Hela cells, the percentage of apoptotic cells was detected by flow cytometry. A total apoptotic rate of 39.8% was observed in the cells not expressing IE86, while the cells treated with Doxycycline (at 0.1 and 1.0 mg/ml) survived exposure to TNF-. These observations are consistent with the previous report of Zhu et al. 6) except for a lower apoptotic rate in our study. The reason for this discrepancy is presumably the ''leaky'' expression of IE86 that was observed in western blots. In the cells induced with Doxycycline at 5.0 mg/ml, early apoptosis was observed. Given that Doxycycline treatment does not affect cell viability and that the expression of IE86 was a little lower, at 5.0 mg/ml of Doxycycline, than the 0.1 mg/ml in our experiment, we propose that the early apoptosis was caused by reduced expression of IE86. We interpret our data to indicate that to a certain extent the anti-apoptotic activity of IE86 correlates with its expression level.
It remains unclear how IE86 inhibits apoptosis in infected cells. A recent study has shown that IE86 activates the endocellular PI3/Akt kinase pathway, which is involved in cell survival. 28) Once Akt is activated it can phosphorylate a number of factors that enhance cell survival, for example, Bad, caspase 9, and IB kinase. Phosphorylated IB kinase phosphorylates IB, releasing NF-B for nuclear entry. 28) Activation of NF-B positively regulates the expression of genes that mediate inflammatory responses in lymphocytes and inhibits TNF-induced apoptosis in several cell types, including fibroblasts, sensory neurons, and oligodendrocytes. [29] [30] [31] Additionally, a previous study showed that IE86 can induce NF-kB transcriptional activity by transactivating a NF-kB subunit, p65 promotor. 13) These data suggest that NF-kB is activated by IE86 and contributes to the anti-apoptotic activity of the viral protein in cells infected with HCMV.
Tumor suppressor p53 protein is another important regulator of cell survival. Levels of p53 become elevated and can induce apoptosis in response to the adenovirus E1A protein, DNA damage, and other stimuli in certain cell types. 32) Recently, Fukui et al. reported that the p53 signal pathway is also involved in TNF-induced apoptosis. 33) Thus, it is possible that IE86 inhibits apoptosis in part by modulating the activity of p53. To test this possibility, we investigated the expression level of p53 mRNA in our study. We failed to detect any difference between cells expressing IE86 and those not expressing this viral protein in the two cell lines, tetIE86Hel and MRC-5, tested. This result indicates that IE86 does not affect the expression of p53. It has also been reported that IE86 downregulates the transcriptional activity of p53 either through interaction with p53 directly or through inhibition of HAT activity. 12, 34) This activity of IE86 protected cells from p53-mediated apoptosis in cultured smooth muscle cells.
11) These observations combined with our results suggest that IE86 probably inhibits cell apoptosis by modulating the function of p53 rather than its expression.
In summary, we report the ability of IE86 to inhibit TNF-induced apoptosis. Expression of this viral protein did not alter the expression level of p53. As an important viral protein, IE86 plays a critical role in the regulation of virus replication and gene transcription as well as apoptosis. Inhibition of apoptosis induced by HCMV IE86 is a very complex event that occurs soon after virus infection, and additional efforts are needed to elucidate the details.
